The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995–2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417257 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Martin Tobi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, John D. Dingell VAMC, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, The Veterans Administration, Research and Development, Merit Review grants, the Kaiser Permanente Research Foundation.
Abstract (Originalsprache)
Given the need to improve the sensitivity of non-invasive methods to detect colorectal neoplasia, particularly adenomas, we compared a fecal test using a monoclonal antibody (Mab) raised against constituents of colonic adenomas designated Adnab-9 (Adenoma Antibody 9), recognizing an N-linked 87 kDa glycoprotein, to gFOBT, which is shown to reduce CRC mortality. p87 immunohistochemistry testing is significantly more sensitive (OR 3.64[CI 2.37–5.58]) than gFOBT (guaiac-based fecal occult blood test) for adenomas (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Development, John D. Dingell VAMC, Detroit, MI 48201, USA.
- Department of Research and Development, Philadelphia VAMC, Philadelphia, PA 19104, USA.
- Nashville Hospital Association, Nashville, TN 37027, USA.
- Departments of Medicine, State University of Pennsylvania, State College, PA 16802, USA.
- New York Medical College, Touro University, Valhalla, NY 10595, USA.
- Detroit Medical Center, Wayne State University School of Medicine, Detroit, MI 48201, USA.
ORCID-Profile: David Kaplan, Rebecca Rodriguez, Yosef Y Tobi, Benita McVicker
Förderung
- BLRD VA
- The Veterans Administration, Research and Development, Merit Review grants
- the Kaiser Permanente Research Foundation
Zitieren
APA
Tobi, M., Antaki, F., Rambus, M. A., Yang, Y. X., Kaplan, D., Rodriguez, R., Maliakkal, B., Majumdar, A., Demian, E., Tobi, Y. Y., Sochacki, P., Ehrinpreis, M., Lawson, M. G., & McVicker, B. (2023). The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995–2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417257
Vancouver
Tobi M, Antaki F, Rambus MA, Yang YX, Kaplan D, Rodriguez R, et al. The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995–2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417257
BibTeX
@article{Tobi2023,
author = {Tobi, Martin and Antaki, Fadi and Rambus, Mary Ann and Yang, Yu-Xiao and Kaplan, David and Rodriguez, Rebecca and Maliakkal, Benedict and Majumdar, Adhip and Demian, Ereny and Tobi, Yosef Y and Sochacki, Paula and Ehrinpreis, Murray and Lawson, Michael G and McVicker, Benita},
title = {The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995–2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417257}
}
EUVIMED